Scrip dividend reference price

RNS Number : 4901S
Primary Health Properties PLC
14 July 2022
 

 

Primary Health Properties PLC

 

(the "Company")

 

Scrip Dividend Scheme

 

The Company announces that the scrip dividend reference price for the third quarterly interim dividend in 2022 (the "Interim Dividend"), payable on 19 August 2022, is 138.14 pence.  

 

The reference price is the price at which Primary Health Properties PLC ordinary shares of 12.5p each ("Ordinary shares") will be issued to shareholders who have elected to receive shares in lieu of cash dividends through participation in the Scrip Dividend Scheme.  The reference price is the average of the closing middle market quotations of the Ordinary shares derived from the London Stock Exchange Daily Official List for the day on which the Ordinary shares were first quoted as ex-dividend (7 July 2022) and the four subsequent dealing days (being 8,11,12 and 13 July 2022).

 

Any shareholders entitled to the Interim Dividend who do not already participate in the Scrip Dividend Scheme (or whose mandates have expired or are not deemed valid and effective) and wish to do so, may obtain a mandate form either by contacting the Company's Registrar, Equiniti, on 0871 384 2268, or by downloading from the Company's website www.phpgroup.co.uk/Investors, or from the National Storage Mechanism. This form must be completed and returned to Equiniti to arrive no later than the close of business on 5 August 2022 in order for it to be effective for the Interim Dividend.

 

 

Contacts:

 

Paul Wright, Company Secretary

Telephone: 0203 833 3344

 

Legal Entity Identifier: 213800Y5CJHXOATK7X11

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVRIMLTMTIBMAT
UK 100

Latest directors dealings